Invention Grant
- Patent Title: Combination therapy with an anti-CD25 antibody-drug conjugate
-
Application No.: US16605708Application Date: 2018-04-20
-
Publication No.: US11596696B2Publication Date: 2023-03-07
- Inventor: Patricius Hendrikus Cornelis Van Berkel , Lisa Skelton , Francesca Zammarchi , Jay Marshall Feingold , Jens Wuerthner , John Hartley
- Applicant: ADC Therapeutics SA , Medimmune Limited
- Applicant Address: CH Epalinges; GB Cambridge
- Assignee: ADC Therapeutics SA,Medimmune Limited
- Current Assignee: ADC Therapeutics SA,Medimmune Limited
- Current Assignee Address: CH Epalinges; GB Cambridge
- Agency: Medler Ferro Woodhouse & Mills PLLC
- Priority: GB1706245 20170420,GB1706246 20170420,GB1706247 20170420,GB1706248 20170420,GB1706249 20170420,GB1706250 20170420,GB1706251 20170420,GB1706252 20170420,GB1805189 20180329
- International Application: PCT/EP2018/060214 WO 20180420
- International Announcement: WO2018/193104 WO 20181025
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61K31/5517 ; A61K31/7068 ; A61K31/7076 ; C07K16/28
Abstract:
The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer. In particular, the present disclosure relates to combination therapies comprising treatment with an Antibody Drug Conjugate (ADC) and a secondary agent.
Public/Granted literature
- US20220016259A1 COMBINATION THERAPY WITH AN ANTI-CD25 ANTIBODY-DRUG CONJUGATE Public/Granted day:2022-01-20
Information query
IPC分类:
